DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
APD791 is an investigational drug.
There have been 4 clinical trials for APD791. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2007.
The most common disease conditions in clinical trials are Acute Coronary Syndrome and [disabled in preview]. The leading clinical trial sponsors are Arena Pharmaceuticals, IlDong Pharmaceutical Co Ltd, and Asan Medical Center.
Recent Clinical Trials for APD791
|Dose-escalation, Repeated and Single Oral Dosing Study||Asan Medical Center||Phase 1|
|Dose-escalation, Repeated and Single Oral Dosing Study||IlDong Pharmaceutical Co Ltd||Phase 1|
|Safety Study of APD-791 With Aspirin and/or Clopidogrel||Asan Medical Center||Phase 1|